Concepedia

K Shiraki

KS

11

Publications

182

Citations

11

H-Index

1993

Active since

Affiliations

Astellas Pharma (Japan)(Current)

Hiroshima University

Tottori University

K Shiraki is an author at Astellas Pharma (Japan) specializing in medicine, cancer research, and pharmacotherapy.

Top concepts

Publications per year

1993–2017

11

Publications

11

Prevention by long-term fermented miso of induction of colonic aberrant crypt foci by azoxymethane in F344 rats

Masayuki Ohara, Huiling Lü, K Shiraki et al. · Oncology Reports · 2002 · 27 citations

Hepatotoxicity and consequently increased cell proliferation are associated with flumequine hepatocarcinogenesis in mice

Midori Yoshida, Katsuhiro Miyajima, K Shiraki et al. · Cancer Letters · 1999 · 27 citations

, , +14

Immunodeficiency with increased immunoglobulin M associated with growth hormone insufficiency

Takehiko Ohzeki, Keiichi Hanaki, Hiroko Motozumi et al. · Acta Paediatrica · 1993 · 20 citations

Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan

Tsutomu Takeuchi, Kota Ishida, K Shiraki et al. · Modern Rheumatology · 2017 · 20 citations · Full text

Antidiabetic effects of dipeptidyl peptidase–IV inhibitors and sulfonylureas in streptozotocin-nicotinamide–induced mildly diabetic mice

Akiko Matsuyama‐Yokono, Atsuo Tahara, Ryosuke Nakano et al. · Metabolism · 2009 · 17 citations

, , +7

Rows per page

1–5 of 11